ArticleThe journal of liquid biopsy2026

Circulating tumor DNA tumor fraction as a biomarker in refractory metastatic colorectal cancer: findings from the CAVE-2 GOIM trial.

Davide Ciardiello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.